Characterization of a Human Hematopoietic Progenitor Cell Capable of Forming Blast Cell Containing Colonies in Vitro

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1988 Sep 1

PMID 3047166

Citations 15

Authors

J Brandt

N Baird

L Lu

E Srour

R Hoffman

Affiliations

Soon will be listed here.

Abstract

A hematopoietic cell (CFU-B1) capable of producing blast cell containing colonies in vitro was detected using a semisolid culture system. The CFU-B1 has the capacity for self-renewal and commitment to a number of hematopoietic lineages. Monoclonal antibody to the human progenitor cell antigen-1 (HPCA-1) and a monoclonal antibody against the major histocompatibility class II antigen (HLA-DR) were used with fluorescence activated cell sorting to phenotype the CFU-B1. The CFU-B1 was found to express My10 but not HLA-DR antigen; experiments using complement-dependent cytotoxicity to eliminate DR positive cells confirmed this finding. Pretreatment of marrow cells with two chemotherapeutic agents, 5-fluorouracil and 4-hydroperoxycyclophosphamide facilitated detection of CFU-B1 derived colonies, while diminishing or totally inhibiting colony formation by other hematopoietic progenitor cells. CFU-B1-derived colony formation was dependent upon the addition of exogenous hematopoietic growth factors. Media conditioned either by the human bladder carcinoma cell line 5637 or lectin stimulated leukocytes, as well as recombinant granulocyte-macrophage colony stimulating factor, interleukin 3 or interleukin 1 alpha promoted blast cell colony formation. By contrast, neither recombinant erythropoietin, recombinant interleukin 4, purified macrophage colony stimulating factor or recombinant granulocyte colony-stimulating factor alone promoted blast cell colony formation.

Citing Articles

Relationship between cell size, cell cycle and specific recombinant protein productivity.

Lloyd D, Holmes P, Jackson L, Emery A, Al-Rubeai M Cytotechnology. 2008; 34(1-2):59-70.

PMID: 19003381 PMC: 3449736. DOI: 10.1023/A:1008103730027.

Proliferation of human hematopoietic bone marrow cells in simulated microgravity.

Plett P, Frankovitz S, Abonour R In Vitro Cell Dev Biol Anim. 2001; 37(2):73-8.

PMID: 11332740 DOI: 10.1290/1071-2690(2001)037<0073:POHHBM>2.0.CO;2.

Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro.

Verfaillie C, Catanzarro P, Li W J Exp Med. 1994; 179(2):643-9.

PMID: 8294873 PMC: 2191371. DOI: 10.1084/jem.179.2.643.

The colony stimulating factors.

Hansson M, Soderstrom T Med Oncol Tumor Pharmacother. 1993; 10(1-2):5-12.

PMID: 8258995 DOI: 10.1007/BF02987762.

Molecular characterization of CD34+ human hematopoietic progenitor cells.

Knapp W, Strobl H, Scheinecker C, Majdic O Ann Hematol. 1995; 70(6):281-96.

PMID: 7543291 DOI: 10.1007/BF01696614.

References

Visser J, Bauman J, Mulder A, Eliason J, de Leeuw A . Isolation of murine pluripotent hemopoietic stem cells. J Exp Med. 1984; 159(6):1576-90. PMC: 2187316. DOI: 10.1084/jem.159.6.1576. View

Zucali J, Dinarello C, Oblon D, Gross M, Anderson L, WEINER R . Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest. 1986; 77(6):1857-63. PMC: 370544. DOI: 10.1172/JCI112512. View

Siena S, Castro-Malaspina H, Gulati S, Lu L, Colvin M, Clarkson B . Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow. Blood. 1985; 65(3):655-62. View

Rowley S, COLVIN O, Stuart R . Human multilineage progenitor cell sensitivity to 4-hydroperoxycyclophosphamide. Exp Hematol. 1985; 13(4):295-8. View

Katz F, Tindle R, Sutherland D, Greaves M . Identification of a membrane glycoprotein associated with haemopoietic progenitor cells. Leuk Res. 1985; 9(2):191-8. DOI: 10.1016/0145-2126(85)90082-7. View

Jubinsky P, Stanley E . Purification of hemopoietin 1: a multilineage hemopoietic growth factor. Proc Natl Acad Sci U S A. 1985; 82(9):2764-8. PMC: 397646. DOI: 10.1073/pnas.82.9.2764. View

Kaizer H, Stuart R, Brookmeyer R, Beschorner W, Braine H, BURNS W . Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood. 1985; 65(6):1504-10. View

Metcalf D . The granulocyte-macrophage colony-stimulating factors. Science. 1985; 229(4708):16-22. DOI: 10.1126/science.2990035. View

Emerson S, Sieff C, Wang E, Wong G, Clark S, Nathan D . Purification of fetal hematopoietic progenitors and demonstration of recombinant multipotential colony-stimulating activity. J Clin Invest. 1985; 76(3):1286-90. PMC: 424044. DOI: 10.1172/JCI112087. View

10.

Falkenburg J, Fibbe W, Goselink H, van Rood J, Jansen J . Human hematopoietic progenitor cells in long-term cultures express HLA-DR antigens and lack HLA-DQ antigens. J Exp Med. 1985; 162(4):1359-69. PMC: 2187875. DOI: 10.1084/jem.162.4.1359. View

11.

Gordon M, Goldman J, Gordon-Smith E . 4-Hydroperoxycyclophosphamide inhibits proliferation by human granulocyte-macrophage colony-forming cells (GM-CFC) but spares more primitive progenitor cells. Leuk Res. 1985; 9(8):1017-21. DOI: 10.1016/0145-2126(85)90072-4. View

12.

PLATZER E, Welte K, GABRILOVE J, Lu L, Harris P, Mertelsmann R . Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells. J Exp Med. 1985; 162(6):1788-801. PMC: 2187980. DOI: 10.1084/jem.162.6.1788. View

13.

Andrews R, Singer J, Bernstein I . Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood. 1986; 67(3):842-5. View

14.

Koike K, Ihle J, Ogawa M . Declining sensitivity to interleukin 3 of murine multipotential hemopoietic progenitors during their development. Application to a culture system that favors blast cell colony formation. J Clin Invest. 1986; 77(3):894-9. PMC: 423476. DOI: 10.1172/JCI112387. View

15.

Rowley S, Zuehlsdorf M, Braine H, COLVIN O, Davis J, Jones R . CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow. Blood. 1987; 70(1):271-5. View

16.

Stanley E, Bartocci A, Patinkin D, Rosendaal M, Bradley T . Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1. Cell. 1986; 45(5):667-74. DOI: 10.1016/0092-8674(86)90781-6. View

17.

Moore M, Warren D . Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. Proc Natl Acad Sci U S A. 1987; 84(20):7134-8. PMC: 299244. DOI: 10.1073/pnas.84.20.7134. View

18.

Lu L, Pelus L, Broxmeyer H, Moore M, Wachter M, Walker D . Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8-positive T lymphocytes and is associated with the density expression of major histocompatibility complex class.... Blood. 1986; 68(1):126-33. View

19.

Broudy V, Zuckerman K, Jetmalani S, Fitchen J, Bagby Jr G . Monocytes stimulate fibroblastoid bone marrow stromal cells to produce multilineage hematopoietic growth factors. Blood. 1986; 68(2):530-4. View

20.

Bagby Jr G, Dinarello C, Wallace P, Wagner C, Hefeneider S, McCall E . Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells. J Clin Invest. 1986; 78(5):1316-23. PMC: 423824. DOI: 10.1172/JCI112717. View